Processa Pharmaceuticals, Inc.·4

Feb 10, 5:20 PM ET

Stanker James H 4

4 · Processa Pharmaceuticals, Inc. · Filed Feb 10, 2023

Insider Transaction Report

Form 4
Period: 2023-02-09
Stanker James H
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-02-09$0.80/sh+12,500$10,00061,750 total

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4